Holdings of the Fund as of 12/12/2025
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,426.00 |
3.28% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$61,123.50 |
2.89% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$52,441.31 |
2.48% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$50,435.76 |
2.39% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$47,739.06 |
2.26% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$47,852.64 |
2.26% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$47,185.52 |
2.23% |
| Waters Corporation |
WAT |
941848103 |
120 |
$46,239.60 |
2.19% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$45,421.48 |
2.15% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$44,780.12 |
2.12% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,587.01 |
2.11% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,311.57 |
2.10% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,339.54 |
2.10% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,175.00 |
2.09% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$44,224.57 |
2.09% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$43,783.50 |
2.07% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,493.28 |
2.06% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,369.69 |
2.05% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,202.84 |
2.04% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$42,990.46 |
2.03% |
| Steris Plc |
STE |
G8473T100 |
169 |
$42,552.51 |
2.01% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,186.93 |
2.00% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$42,377.92 |
2.00% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$41,745.66 |
1.97% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,527.66 |
1.96% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$41,289.42 |
1.95% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$40,979.52 |
1.94% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$40,786.56 |
1.93% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$40,669.12 |
1.92% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,372.74 |
1.91% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$38,698.44 |
1.83% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,690.12 |
1.83% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$38,704.15 |
1.83% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,595.81 |
1.83% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$38,413.42 |
1.82% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$38,559.39 |
1.82% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$38,288.35 |
1.81% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$38,181.84 |
1.81% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$37,763.46 |
1.79% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$37,721.01 |
1.78% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,551.35 |
1.78% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$37,553.90 |
1.78% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$37,723.19 |
1.78% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$37,183.58 |
1.76% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,083.69 |
1.75% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$36,913.50 |
1.75% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$36,848.15 |
1.74% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$36,163.40 |
1.71% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$34,795.55 |
1.65% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,080.98 |
1.42% |
| US Dollar |
$USD |
|
2,840 |
$2,839.89 |
0.13% |
| New Zealand Dollar |
$NZD |
|
430 |
$249.57 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|